HIV coinfection with hepatitis b other diagnostic studies: Difference between revisions
Created page with "__NOTOC__ {{HIV coinfection with hepatitis b}} {{CMG}} ==Liver Biopsy== Liver biopsy remains the gold standard for assessing disease severity in HIV-HBV coinfection. Non-inv..." |
m Changes made per Mahshid's request |
||
(2 intermediate revisions by one other user not shown) | |||
Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==Liver Biopsy== | ==Other Diagnostic Studies== | ||
===Liver Biopsy=== | |||
Liver biopsy remains the gold standard for assessing disease severity in HIV-HBV coinfection. Non-invasive markers are also available but none have been widely studied in coinfected patients. | Liver biopsy remains the gold standard for assessing disease severity in HIV-HBV coinfection. Non-invasive markers are also available but none have been widely studied in coinfected patients. | ||
Line 9: | Line 11: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Gastroenterology]] | |||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Needs overview]] | [[Category:Needs overview]] |
Latest revision as of 18:01, 18 September 2017
HIV coinfection with hepatitis b Microchapters |
Differentiating HIV coinfection with hepatitis b from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
HIV coinfection with hepatitis b other diagnostic studies On the Web |
American Roentgen Ray Society Images of HIV coinfection with hepatitis b other diagnostic studies |
FDA on HIV coinfection with hepatitis b other diagnostic studies |
CDC on HIV coinfection with hepatitis b other diagnostic studies |
HIV coinfection with hepatitis b other diagnostic studies in the news |
Blogs on HIV coinfection with hepatitis b other diagnostic studies |
Directions to Hospitals Treating HIV coinfection with hepatitis b |
Risk calculators and risk factors for HIV coinfection with hepatitis b other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Other Diagnostic Studies
Liver Biopsy
Liver biopsy remains the gold standard for assessing disease severity in HIV-HBV coinfection. Non-invasive markers are also available but none have been widely studied in coinfected patients.